These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 11737238)

  • 1. Impact of genetic defects on atherosclerosis in patients suspected of familial hypercholesterolaemia.
    Descamps OS; Gilbeau JP; Leysen X; Van Leuven F; Heller FR
    Eur J Clin Invest; 2001 Nov; 31(11):958-65. PubMed ID: 11737238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of genetic defects on coronary atherosclerosis in patients suspected of having familial hypercholesterolaemia.
    Descamps OS; Gilbeau JP; Luwaert R; Heller FR
    Eur J Clin Invest; 2003 Jan; 33(1):1-9. PubMed ID: 12492446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease.
    Wittekoek ME; de Groot E; Prins MH; Trip MD; Büller HR; Kastelein JJ
    Atherosclerosis; 1999 Oct; 146(2):271-9. PubMed ID: 10532683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of carotid atherosclerosis in normocholesterolemic individuals with proven mutations in the low-density lipoprotein receptor or apolipoprotein B genes.
    Huijgen R; Vissers MN; Kindt I; Trip MD; de Groot E; Kastelein JJ; Hutten BA
    Circ Cardiovasc Genet; 2011 Aug; 4(4):413-7. PubMed ID: 21642693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carotid intima-media thickness and plaque in patients with familial hypercholesterolaemia mutations and control subjects.
    Tonstad S; Joakimsen O; Stensland-Bugge E; Ose L; Bønaa KH; Leren TP
    Eur J Clin Invest; 1998 Dec; 28(12):971-9. PubMed ID: 9893006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia.
    Rubba P; Gentile M; Marotta G; Iannuzzi A; Sodano M; De Simone B; Jossa F; Iannuzzo G; Giacobbe C; Di Taranto MD; Fortunato G
    Eur J Prev Cardiol; 2017 Jul; 24(10):1051-1059. PubMed ID: 28353356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effect of two low-density lipoprotein receptor class mutations on coronary heart disease among French-Canadian patients heterozygous for familial hypercholesterolaemia.
    Vohl MC; Gaudet D; Moorjani S; Tremblay G; Perron P; Gagné C; Lesiège D; Bergeron J; Lupien PJ; Després JP
    Eur J Clin Invest; 1997 May; 27(5):366-73. PubMed ID: 9179542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Femoral atherosclerosis in heterozygous familial hypercholesterolemia: influence of the genetic defect.
    Junyent M; Gilabert R; Zambón D; Pocoví M; Mallén M; Cofán M; Núñez I; Civeira F; Tejedor D; Ros E
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):580-6. PubMed ID: 18096825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intima-media thickness and atherosclerotic plaques in familial defective apolipoprotein B-100 and familial hypercholesterolemia.
    Kaiser M; Temelkova-Kurktschiev T; Hanefeld M
    Ann N Y Acad Sci; 2002 Jun; 967():528-34. PubMed ID: 12079884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial hypercholesterolaemia in a Belgian community.
    Descamps OS
    Acta Cardiol; 2000 Dec; 55(6):327-33. PubMed ID: 11227832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of low-density lipoprotein receptor mutational class on carotid atherosclerosis in patients with familial hypercholesterolemia.
    Junyent M; Gilabert R; Jarauta E; Núñez I; Cofán M; Civeira F; Pocoví M; Mallén M; Zambón D; Almagro F; Vega J; Tejedor D; Ros E
    Atherosclerosis; 2010 Feb; 208(2):437-41. PubMed ID: 19717150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive family history for coronary heart disease and 'midband lipoproteins' are potential risk factors of carotid atherosclerosis in familial hypercholesterolemia.
    Taira K; Bujo H; Kobayashi J; Takahashi K; Miyazaki A; Saito Y
    Atherosclerosis; 2002 Feb; 160(2):391-7. PubMed ID: 11849663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased carotid artery intima-media thickness is associated with a novel mutation of low-density lipoprotein receptor independently of major cardiovascular risk factors.
    Pauciullo P; Giannino A; De Michele M; Gentile M; Liguori R; Argiriou A; Carlotto A; Faccenda F; Mancini M; Bond MG; De Simone V; Rubba P
    Metabolism; 2003 Nov; 52(11):1433-8. PubMed ID: 14624402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density lipoprotein levels and not mutation status predict intima-media thickness in familial hypercholesterolemia.
    Fahed AC; Habib RH; Nemer GM; Azar ST; Andary RR; Arabi MT; Moubarak EM; Bitar FF; Haddad FF
    Ann Vasc Surg; 2014 Feb; 28(2):421-6. PubMed ID: 24120234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia.
    Leus FR; Wittekoek ME; Prins J; Kastelein JJ; Voorbij HA
    Atherosclerosis; 2000 Apr; 149(2):371-7. PubMed ID: 10729387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.
    Heath KE; Gudnason V; Humphries SE; Seed M
    Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia.
    Tada H; Kawashiri MA; Nohara A; Inazu A; Mabuchi H; Yamagishi M
    Eur Heart J; 2017 May; 38(20):1573-1579. PubMed ID: 28159968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDL receptor mutation genotype and vascular disease phenotype in heterozygous familial hypercholesterolaemia.
    Brorholt-Petersen JU; Jensen HK; Jensen JM; Refsgaard J; Christiansen T; Hansen LB; Gregersen N; Faergeman O
    Clin Genet; 2002 Jun; 61(6):408-15. PubMed ID: 12121347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin therapy in a kindred with both apolipoprotein B and low density lipoprotein receptor gene defects.
    Raal FJ; Pilcher G; Rubinsztein DC; Lingenhel A; Utermann G
    Atherosclerosis; 1997 Feb; 129(1):97-102. PubMed ID: 9069523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control study.
    Bos S; Duvekot MH; Ten Kate GR; Verhoeven AJ; Mulder MT; Schinkel AF; Nieman K; Watts GF; Sijbrands EJ; Roeters van Lennep JE
    Atherosclerosis; 2017 Jan; 256():62-66. PubMed ID: 28012444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.